Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jaya Chakravarty & Shyam Sundar. (2019) Current and emerging medications for the treatment of leishmaniasis. Expert Opinion on Pharmacotherapy 20:10, pages 1251-1265.
Read now
Read now
Yavuz Yesilova, Hacer Altın Surucu, Nurittin Ardic, Mustafa Aksoy, Abdullah Yesilova, Steve Oghumu & Abhay R. Satoskar. (2016) Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis. Journal of Dermatological Treatment 27:1, pages 83-87.
Read now
Read now
Shyam Sundar & Jaya Chakravarty. (2015) An update on pharmacotherapy for leishmaniasis. Expert Opinion on Pharmacotherapy 16:2, pages 237-252.
Read now
Read now
Shyam Sundar & Jaya Chakravarty. (2013) Leishmaniasis: an update of current pharmacotherapy. Expert Opinion on Pharmacotherapy 14:1, pages 53-63.
Read now
Read now
Ranthilaka R. Ranawaka & Hema S. Weerakoon. (2010) Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani. Journal of Dermatological Treatment 21:5, pages 286-293.
Read now
Read now
F. Iraji & A. Sadeghinia. (2005) Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran. Annals of Tropical Medicine & Parasitology 99:1, pages 3-9.
Read now
Read now
Articles from other publishers (39)
Hend Alotaibi, Abdulelah Aldossari & Sultan Alnasser. (2023) Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review. Tropical Medicine and Infectious Disease 8:9, pages 443.
Crossref
Crossref
Rajamanthrilage Kasun Madusanka, Hermali Silva & Nadira D. Karunaweera. (2022) Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review. Infectious Diseases and Therapy 11:2, pages 695-711.
Crossref
Crossref
Liliana López, Braulio Valencia, Fiorela Alvarez, Ana Pilar Ramos, Alejandro Llanos-Cuentas, Juan Echevarria, Iván Vélez, Marina Boni, Joelle Rode, Juliana Quintero, Alejandra Jiménez, Yulied Tabares, Claudia Méndez & Byron Arana. (2022) A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World. PLOS Neglected Tropical Diseases 16:3, pages e0010238.
Crossref
Crossref
Rasit Dinc. (2022) New developments in the treatment of cutaneous leishmaniasis. Asian Pacific Journal of Tropical Medicine 15:5, pages 196.
Crossref
Crossref
Dindar S. Qurtas & Nazar Pauls Shabila. (2020) Using Q-methodology to understand the perspectives and practical experiences of dermatologists about treatment difficulties of cutaneous leishmaniasis. BMC Infectious Diseases 20:1.
Crossref
Crossref
H. Husein‐ElAhmed, U. Gieler & M. Steinhoff. (2020) Evidence supporting the enhanced efficacy of pentavalent antimonials with adjuvant therapy for cutaneous leishmaniasis: a systematic review and meta‐analysis. Journal of the European Academy of Dermatology and Venereology 34:10, pages 2216-2228.
Crossref
Crossref
Amir Hossein Siadat, Azadeh Zolfaghari, Zabiholah Shahmoradi, Sheila Shariat & Karim Sohrabi. (2020) Application of laser for treatment of cutaneous leishmaniasis: a review of literature. Lasers in Medical Science 35:7, pages 1451-1457.
Crossref
Crossref
Naomi E. Aronson & Christie A. Joya. (2019) Cutaneous Leishmaniasis. Infectious Disease Clinics of North America 33:1, pages 101-117.
Crossref
Crossref
Taisa Rocha Navasconi Berbert, Tatiane França Perles de Mello, Priscila Wolf Nassif, Camila Alves Mota, Aline Verzignassi Silveira, Giovana Chiqueto Duarte, Izabel Galhardo Demarchi, Sandra Mara Alessi Aristides, Maria Valdrinez Campana Lonardoni, Jorge Juarez Vieira Teixeira & Thaís Gomes Verziganassi Silveira. (2018) Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review. Dermatology Research and Practice 2018, pages 1-21.
Crossref
Crossref
Soner Uzun, Mehmet S. Gürel, Murat Durdu, Melih Akyol, Bilge Fettahlıoğlu Karaman, Mustafa Aksoy, Sema Aytekin, Murat Borlu, Esra İnan Doğan, Çiğdem Asena Doğramacı, Yelda Kapıcıoğlu, Ayşe Akman-Karakaş, Tamer İ. Kaya, Mehmet K. Mülayim, Yusuf Özbel, Seray Özensoy Töz, Orhan Özgöztaşı, Yavuz Yeşilova & Mehmet Harman. (2018) Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. International Journal of Dermatology 57:8, pages 973-982.
Crossref
Crossref
Alberto E. Paniz-Mondolfi, Carolina Talhari, María F García Bustos, Tamara Rosales, Wilmer E. Villamil-Gomez, Marilianna Marquez, Alexandra M. Pérez Alvarez, Alejandra I. Tálamo Sánchez & Alfonso J. Rodriguez-Morales. (2017) American cutaneous leishmaniasis in infancy and childhood. International Journal of Dermatology 56:12, pages 1328-1341.
Crossref
Crossref
Nayara Castelano Brito, Ana Rabello & Gláucia Fernandes Cota. (2017) Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PLOS ONE 12:9, pages e0184777.
Crossref
Crossref
Chonny Herrera Acevedo, Luciana Scotti, Mateus Feitosa Alves, Margareth Formiga Melo Diniz & Marcus Scotti. (2017) Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases. Molecules 22:1, pages 79.
Crossref
Crossref
Bradford S. McGwire & Abhay R. Satoskar. (2016) Treatment Options for Leishmaniasis. Current Clinical Microbiology Reports 3:4, pages 198-203.
Crossref
Crossref
Jonathan Berman, Julia Toledo, Jaime Soto, Jorge Quispe, Paula Soto, Daniela Rivero & David Paz. (2016) Intralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous Leishmaniasis. The American Journal of Tropical Medicine and Hygiene 94:4, pages 852-856.
Crossref
Crossref
Erfan Ayubi, Ahad Ashrafi-Asgarabad, Saeid Safiri, Ahmad Kousha, Mohammad Baniasadi & Christoph Augner. (2015) Post-treatment Clinical Outcomes of Cutaneous Leishmaniosis in the Bam Area, South Eastern Iran: Analysis of over 9,000 Cases. International Journal of Infectious Diseases 34, pages 61-65.
Crossref
Crossref
Hans-Christian Stahl, Faridullah Ahmadi, Ulrike Schleicher, Rainer Sauerborn, Justo Lorenzo Bermejo, Mohammed Latif Amirih, Ibrahim Sakhayee, Christian Bogdan & Kurt-Wilhelm Stahl. (2014) A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC Infectious Diseases 14:1.
Crossref
Crossref
Caspar J. Hodiamont, Piet A. Kager, Aldert Bart, Henry J. C. de Vries, Pieter P. A. M. van Thiel, Tjalling Leenstra, Peter J. de Vries, Michèle van Vugt, Martin P. Grobusch & Tom van Gool. (2014) Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide. PLoS Neglected Tropical Diseases 8:5, pages e2832.
Crossref
Crossref
B. S. McGwire & A. R. Satoskar. (2013) Leishmaniasis: clinical syndromes and treatment. QJM 107:1, pages 7-14.
Crossref
Crossref
Bradford S. McGwire. 2014. Pathogenesis of Leishmaniasis. Pathogenesis of Leishmaniasis
77
90
.
Begoña Monge-Maillo & Rogelio López-Vélez. (2013) Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis. Drugs 73:17, pages 1889-1920.
Crossref
Crossref
G. Morizot, E. Kendjo, O. Mouri, M. Thellier, A. Pérignon, F. Foulet, F. Cordoliani, E. Bourrat, E. Laffitte, I. Alcaraz, N. Bodak, C. Ravel, M. Vray, M. Grogl, D. Mazier, E. Caumes, L. Lachaud, P. A. Buffet, Y. El Samad, V. Salle, N. Gounod, A. Dallot, G. Belot, S. Pelletier-Cunat, M. Belon, R. Verdon, O. Rogeaux, G. Grossetête, O. Lesens, A. Clabaut, E. Maus, L. Jouy, G. Gener, P. Perrin, N. Roch, A. Herve, D. Le Duc, E. Cuchet, D. Maubon, B. Hillion, E. Menot, F. Guillemot, N. Beneton-Benhard, P. Celerier, A. L. Dupuis De Fonclare, D. Carre, A. Bourgeois, P. Marty, C. Pomares, L. Meunier, H. Abergel, F. Timsit, J. C. Amoric, P. Busquet, S. Karam, Y. F. Moisson, F. Mouly, J. C. Ortoli, P. H. Consigny, M. Jouan, F. Caby, A. Datry, P. Hochedez, F. Rozembaum, C. Dumortier, T. Ancelle, N. Dupin, A. Paugam, B. Ranque, M. E. Bougnoux, A. Canestri, M. F. Galezowsky, S. Hadj Rabia, D. Hamel, P. Schneider, M. Wolter-Desfosses, M. Janier, M. Baccard, M. Bezier, M. Broissin, N. Colin De Verdiere, F. Durupt, E. Hope Rapp, C. Juillard, A. Levy, I. Moraillon, A. Petit, S. Regner, D. Barthelme, J. M. Tamarin, E. Begon, C. Strady, J. P. Gangneux, O. Carpentier, F. Mechai, C. Kieffer, P. Dellestable & S. Rebauder. (2013) Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy. Clinical Infectious Diseases 57:3, pages 370-380.
Crossref
Crossref
Alireza Khatami, Rezvan Talaee, Makan Rahshenas, Ali Khamesipour, Pedram Mehryan, Sepideh Tehrani, Yahya Dowlati & Alireza Firooz. (2013) Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial. PLoS ONE 8:6, pages e66123.
Crossref
Crossref
Johannes Blum, Diana N.J. Lockwood, Leo Visser, Gundel Harms, Mark S. Bailey, Eric Caumes, Jan Clerinx, Pieter P.A.M. van Thiel, Gloria Morizot, Christoph Hatz & Pierre Buffet. (2012) Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. International Health 4:3, pages 153-163.
Crossref
Crossref
Ram K. Tanwar, Ram A. Bumb, Abhay R. Satoskar, Rajesh D. Mehta, Neha Prasad & Anil A. Ahuja. (2012) Successful Treatment of Canine Cutaneous Leishmaniasis Using Radio-Frequency Induced Heat (RFH) Therapy. The American Journal of Tropical Medicine and Hygiene 87:2, pages 261-263.
Crossref
Crossref
Maryam Ghadiri, Alireza Vatanara, Delaram Doroud & A. Roholamini Najafabadi. (2011) Paromomycin loaded solid lipid nanoparticles: Characterization of production parameters. Biotechnology and Bioprocess Engineering 16:3, pages 617-623.
Crossref
Crossref
Pierre A. Buffet, Éric Rosenthal, Jean-Pierre Gangneux, Edward Lightburne, Pierre Couppié, Gloria Morizot, Laurence Lachaud, Pierre Marty & Jean-Pierre Dedet. (2011) Traitement des leishmanioses en France : proposition d’un référentiel consensuel. La Presse Médicale 40:2, pages 173-184.
Crossref
Crossref
Omar Lupi, Brenda L. Bartlett, Reshma Nair Haugen, Lady C. Dy, Aisha Sethi, Sidney N. Klaus, Jackson Machado Pinto, Francisco Bravo & Stephen K. Tyring. (2009) Tropical dermatology: Tropical diseases caused by protozoa. Journal of the American Academy of Dermatology 60:6, pages 897-925.
Crossref
Crossref
Afif Ben Salah, Pierre A. Buffet, Gloria Morizot, Nathalie Ben Massoud, Amor Zâatour, Nissaf Ben Alaya, Nabil Bel Haj Hamida, Zaher El Ahmadi, Matthew T. Downs, Philip L. Smith, Koussay Dellagi & Max Grögl. (2009) WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study. PLoS Neglected Tropical Diseases 3:5, pages e432.
Crossref
Crossref
Johannes A. Blum & Christoph F. Hatz. (2009) Treatment of Cutaneous Leishmaniasis in Travelers 2009. Journal of Travel Medicine 16:2, pages 123-131.
Crossref
Crossref
H. Chaabane, A. Masmoudi, A. Dammak, W. Kchaou, F. Akrout, M. Zribi, S. Boudaya & H. Turki. (2009) Traitement de la leishmaniose cutanée par cryothérapie associée ou non au Glucantime® intralésionnel. Annales de Dermatologie et de Vénéréologie 136:3, pages 278-279.
Crossref
Crossref
P. Buffet. (2008) Leishmaniose cutanée. EMC - Dermatologie 3:4, pages 1-11.
Crossref
Crossref
Richard Reithinger & Paul G Coleman. (2007) Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. BMC Infectious Diseases 7:1.
Crossref
Crossref
Hervé Lecoeur, Pierre Buffet, Gloria Morizot, Sophie Goyard, Ghislaine Guigon, Geneviève Milon & Thierry Lang. (2007) Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL/6 Model. PLoS Neglected Tropical Diseases 1:2, pages e34.
Crossref
Crossref
Alireza Khatami, Alireza Firooz, Farzam Gorouhi & Yahya Dowlati. (2007) Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials. Journal of the American Academy of Dermatology 57:2, pages 335.e1-335.e29.
Crossref
Crossref
G. Sadeghian, M. A. Nilfroushzadeh & F. Iraji. (2007) Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clinical and Experimental Dermatology 32:4, pages 371-374.
Crossref
Crossref
Philippe Minodier & Philippe Parola. (2007) Cutaneous leishmaniasis treatment. Travel Medicine and Infectious Disease 5:3, pages 150-158.
Crossref
Crossref
G. Sadeghian & M. A. Nilforoushzadeh. (2006) Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. International Journal of Dermatology 45:7, pages 819-821.
Crossref
Crossref
Henry W Murray, Jonathan D Berman, Clive R Davies & Nancy G Saravia. (2005) Advances in leishmaniasis. The Lancet 366:9496, pages 1561-1577.
Crossref
Crossref